Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.
Eur J Cardiothorac Surg. 2021 Sep 11;60(3):633-641. doi: 10.1093/ejcts/ezab143.
Infection of the native aorta or after previous open or endovascular repair of the thoracic aorta is associated with high risks for morbidity and mortality. We analysed the outcome after surgical management of a native mycotic aneurysm or of prosthetic graft infection of the descending aorta.
From June 2000 to May 2019, a total of 39 patients underwent surgery in our centre for infection of the native descending aorta (n = 19 [49%], group A) or a prosthetic descending aorta [n = 20 (51%), group B]. In the 20 patients in group B, a total of 8 patients had prior open aortic repair with a prosthesis and 12 patients had a previous endovascular graft repair.
The cohort patients had a mean age of 57 ± 14; 62% were men (n = 24). The most common symptoms at the time of presentation included fever, thoracic or abdominal pain and active bleeding. Emergency surgery was performed in 11 patients (28%); 3 patients had emergency endovascular stent grafts implanted during thoracic endovascular aortic repair for aortic rupture before further open repair. The 30-day mortality was 42% in group A and 35% in group B. The 90-day mortality was 47% in group A and 45% in group B. Pathogens could be identified in approximately half of the patients (46%). The most commonly identified pathogens were Staphylococcus aureus in 6 patients (15%) and Staphylococcus epidermidis in 4 patients (10%). Survival of the entire group (including patients with both native and prosthetic graft infections) was 44 ± 8%, 39 ± 8% and 39 ± 8% at 1, 2 and 3 years after surgery. The percentage of patients who survived the initial perioperative period was 81 ± 9%, 71 ± 9% and 71 ± 10% at 1, 2 and 3 years after surgery.
Patients with infection of the descending aorta, either native or prosthetic, are associated with both high morbidity and mortality. However, patients who survive the initial perioperative period have an acceptable long-term prognosis. In emergency situations, thoracic endovascular aortic repair may help to stabilize patients and serve as bridge to open repair.
感染原发性主动脉或胸主动脉先前的开放或血管内修复后,发病率和死亡率都很高。我们分析了外科治疗原发性感染性动脉瘤或人造移植物感染降主动脉的结果。
从 2000 年 6 月至 2019 年 5 月,共有 39 名患者在我们中心接受了手术治疗,用于治疗感染性降主动脉(n=19[49%],A 组)或人造降主动脉移植物感染(n=20[51%],B 组)。在 B 组的 20 名患者中,共有 8 名患者曾接受过开放性主动脉修复术和假体治疗,12 名患者曾接受过血管内移植物修复术。
队列患者的平均年龄为 57±14 岁;62%为男性(n=24)。就诊时最常见的症状包括发热、胸痛或腹痛和活动性出血。11 名患者(28%)接受了急诊手术;3 名患者在胸主动脉腔内修复术期间因主动脉破裂而紧急植入了血管内支架移植物,然后再进行进一步的开放修复。A 组的 30 天死亡率为 42%,B 组为 35%。A 组的 90 天死亡率为 47%,B 组为 45%。大约一半的患者(46%)可以确定病原体。最常见的病原体是 6 名患者(15%)的金黄色葡萄球菌和 4 名患者(10%)的表皮葡萄球菌。整个组(包括原发性和移植物感染患者)的存活率分别为术后 1、2 和 3 年的 44±8%、39±8%和 39±8%。在术后 1、2 和 3 年,存活过初始围手术期的患者比例分别为 81±9%、71±9%和 71±10%。
感染性降主动脉,无论是原发性还是人造移植物,都与高发病率和死亡率相关。然而,存活过初始围手术期的患者具有可接受的长期预后。在紧急情况下,胸主动脉腔内修复术可能有助于稳定患者,并作为开放修复的桥梁。